Synthetic ingredients’ regulatory uncertainty still a huge problem for dietary supplements, whether in Amarin’s omega-3 drug battle or in NDI guidance
Amarin Pharma’s recent comments advising FDA not to allow synthetic omega-3 supplements to be dietary supplements is just one more case in which synthetic supplement ingredients are under fire.
CBD may be the hottest ingredient on the block, but don’t overlook hemp’s other promising cannabinoids, including cannabigerol (CBG), cannabichromene (CBC), and cannabinol (CBN). This article discusses exciting avenues of product development for manufacturers looking to work with a wider range of cannabinoids, as well as the challenges that remain.
One CEO writes about how blockchain technology is the key to addressing the complexity of today’s global dietary supplement supply chain.
MCTs are increasingly popular among consumers and product makers, in part due to their ease of use as well as their health benefits.
Researchers are finding that dietary supplementation can go a long way toward shoring up ocular health and protecting eyes against the battery of threats they face.
A brief look at three of the lesser-known health benefits of natural astaxanthin.
In a market segment as old and enduring as grains, one might wonder if further innovation is possible.
ChromaDex CEO Rob Fried: “Although it is uncommon, perhaps, for a company CEO to request stronger regulations and regulatory enforcement for his or her industry, that is precisely what I am doing.”
While plant proteins have been trending, dairy proteins and isolates remain competitive within the protein bar space, specifically within sports nutrition.